Yasuhiro Tarutani Selected Research

Aryldialkylphosphatase (Paraoxonase)

6/2006

Impact of paraoxonase polymorphism (Q192R) on endothelial function in intact coronary circulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Tarutani Research Topics

Disease

4	Thrombosis (Thrombus) 01/2019 - 07/2013
4	Hypertension (High Blood Pressure) 01/2013 - 04/2003
2	Atherosclerosis 06/2006 - 07/2004
1	Pathologic Constriction (Stenosis) 01/2018
1	Myocardial Infarction 10/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2013
1	Renal Insufficiency (Renal Failure) 01/2013
1	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2011
1	Hyperemia 01/2008
1	Body Weight (Weight, Body) 01/2008
1	Stroke (Strokes) 10/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2006

Drug/Important Bio-Agent (IBA)

2	BESIBA 10/2015 - 07/2013
2	LipidsIBA 01/2008 - 07/2004
1	Antihypertensive Agents (Antihypertensives)IBA 01/2013
1	Renin InhibitorsIBA 01/2013
1	aliskiren FDA Link 01/2013
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2011
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2011
1	LipocalinsIBA 01/2011
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2008
1	mahuang-tangIBA 10/2006
1	LDL CholesterolIBA 06/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2006
1	Aryldialkylphosphatase (Paraoxonase)IBA 06/2006
1	oxidized low density lipoproteinIBA 07/2004
1	Perindopril FDA LinkGeneric 04/2003
1	Losartan (Cozaar)FDA LinkGeneric 04/2003

Therapy/Procedure

4	Stents 01/2019 - 07/2013
1	Drug-Eluting Stents 01/2018
1	Therapeutics 01/2013
1	Sublingual Administration 01/2008